Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

PepsiCo May See Lower Q3 Gross Margins From Tariff Pressure, 'Stretched' Frito-Lay Pricing

Nabaparna Bhattacharya
September 26, 2025

PepsiCo, Inc. (NASDAQ: PEP) shares are trading slightly higher on Friday.

The global leader in snacks and beverages remains a “defensive” play in a U.S. slowdown, though less so than in past recessions, given stretched Frito-Lay pricing.

See how PEP stock is doing here.

BofA Securities analyst Peter T. Galbo reiterated the Neutral rating on the stock, with a price forecast of $150.

Galbo still sees the company positioned to deliver steady shareholder returns by balancing growth with dividends and share repurchases.

Also Read: Celsius Takes Control Of Energy Drink Aisle With PepsiCo Partnership

The firm will issue its third-quarter 2025 financial results on Thursday, Oct. 9, 2025.

The analyst maintains a third-quarter EPS estimate of $2.26, and updates his model to reflect lower third-quarter gross margins from tariff pressure, with mitigation expected to begin next quarter.

The analyst trims corporate expense and the effective tax rate to offset, and lowers the IB franchise organic sales outlook to flat from up 3% year over year due to weather in Mexico, Brazil and India.

That change reduces total company third-quarter organic sales to 1.8% from 2%.

Galbo sees limited risk of further sales or EPS revisions as the quarter largely played out as expected, but says fundamentals in PepsiCo’s core businesses, including PFNA, have yet to reaccelerate, keeping sentiment muted.

The analyst writes, PepsiCo Foods North America is showing sluggish sales as the company laps last summer’s promotions. NielsenIQ scanner data for the third quarter of 2025 was largely unchanged from the second quarter and the first half.

At Frito-Lay, PepsiCo cycled difficult comparisons tied to July 4 promotions in summer 2024.

Quaker continues to face easier comparisons following recall-related disruptions through the end of 2025. Frito-Lay reports a “hollowing” of middle-tier price points: premium brands such as Miss Vickie’s and Siete are performing well, as are value labels like Santitas and Chester’s.

By contrast, midprice staples -- Lay’s, Tostitos and Doritos -- continue to post meaningful year-over-year declines in the scanner data, Galbo adds.

PEP Price Action: PEP shares are trading higher by 0.20% to $140.20 at publication on Friday.

Read Next:

  • What’s Costco’s Secret To Staying Profitable In Uncertain Times?

Photo: Shutterstock

Continue Reading...

Popular

Trump administration puts on hold $18 billion in funding for New York City infrastructure projects

WASHINGTON (AP) — President Donald Trump's administration said Wednesday it was putting a hold on roughly $18 billion to fund beneath the Hudson River between New York City and New Jersey and the city's expanded project because of .

Benzinga Bulls And Bears: Oracle, Costco, NIO — And Wall Street Snaps Its Slide

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Turn Your "Dead Money" Into $306+ Monthly (Starting This Month) - Ad

I've been tracking a financial revolution that most people don't even know exists yet. It lets you generate $306 to $5,000 per month in retirement income... With 10X less money than what financial advisors say you need! This is a new type of investment you can buy with one click in your brokerage account.

Trump files $15 billion defamation lawsuit against The New York Times

NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Hit Your Retirement "Freedom Number" (Without $1 Million) - Ad

Retirement should be freedom, not stress. Yet outdated advice and tiny returns leave many trapped. Kelly G. broke free with a revolutionary income strategy once reserved for the wealthy - hitting her "Freedom Number" faster than she dreamed. You might already have enough too.

Elon Musk And Sam Altman May Not Agree On Everything, But On This One Topic Their Ideas Align

OpenAI CEO Sam Altman sparked debate by saying society was "better off with phone call culture," echoing other tech leaders and research showing most meetings kill productivity.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.22%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.78 billion.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs

President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks. 

Trump and Xi are set to discuss the TikTok deal and future of US-China relations

WASHINGTON (AP) — U.S. is expected to talk with Chinese leader Xi Jinping on Friday in a push to finalize a deal to allow the popular social media app in the United States.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Oracle Surges Over 3% In Pre-Market Amid TikTok Deal Speculation, AI Infrastructure Momentum

Oracle's stock continues to rise, driven by the potential TikTok acquisition and strong AI infrastructure positioning, with a 81.31% gain in 2025.

Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico

U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.

FedEx Bets On Cost Cuts To Boost Margins, Says Analyst

FDX shares surge on strong quarterly performance, exceeding revenue and profit expectations. Bank of America raises price forecast to $244.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

$1000 Invested In Federal Signal 10 Years Ago Would Be Worth This Much Today

Federal Signal (NYSE: FSS) has outperformed the market over the past 10 years by 11.38% on an annualized basis producing an average annual return of 24.51%. Currently, Federal Signal has a market capitalization of $7.47 billion.

Intel, Fedex, Lennar, Brera Holdings And Rivian: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,142.42. The S&P 500 advanced 0.5% to 6,631.96, while the Nasdaq climbed nearly 1% to 22,470.73.These are the top stocks that gained the attention of retail traders and investors through the day:

Hit Your Retirement Income Goal With 10X Less Money - Ad

Financial advisors say you need $1.5M to generate $5,000/month. A revolutionary new investment does it with potentially $150,000. Kelly G: "I updated my spreadsheet and it seems illegal. The income keeps growing." Transform non-dividend stocks like Apple and Tesla into monthly income machines. Bloomberg reports they're "entering a golden era." Simple as buying a stock.

Rivals Compass and Anywhere Real Estate to combine in deal valued at $10 billion including debt

Two of the nation's biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

uCloudlink's GlocalMe Taps Into U.S. Pet Boom With PetPhone After Market Re-Entry

uCloudlink Group's consumer brand GlocalMe is making a renewed push into the U.S. with the launch of PetPhone, an AI-powered device designed to let pets and owners stay connected.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Toyota and Hyundai recall more than 1.1 million vehicles for seat belt, panel display problems

Toyota and Hyundai are recalling a combined 1.1 million vehicles due to problems with the instrument panel displays and seat belts, U.S. auto regulators said Thursday.

Turn Your "Dead Money" Into $306+ Monthly (Starting This Month) - Ad

I've been tracking a financial revolution that most people don't even know exists yet. It lets you generate $306 to $5,000 per month in retirement income... With 10X less money than what financial advisors say you need! This is a new type of investment you can buy with one click in your brokerage account.

Scott Bessent Heads To Madrid For High-Stakes Talks With China As TikTok Deadline Looms, Tariff Pressures Escalate

U.S. Treasury Secretary Scott Bessent will meet Chinese Vice Premier He Lifeng in Madrid next week for high-stakes talks on tariffs, agriculture and TikTok's looming U.S. divestment deadline, as trade tensions deepen with Chinese exports to the U.S. plunging 33%.

Mark Zuckerberg Warns AI Boom Could Mirror Dot-Com Bubble: '...Something Like That Would Happen Here'

Meta CEO Mark Zuckerberg warned that AI could spark a bubble like the dot-com era, saying there is "definitely a possibility" of a market crash, but argued the greater danger lies in underinvesting in what he views as a transformative technology.

Hit Your Retirement "Freedom Number" (Without $1 Million) - Ad

Retirement should be freedom, not stress. Yet outdated advice and tiny returns leave many trapped. Kelly G. broke free with a revolutionary income strategy once reserved for the wealthy - hitting her "Freedom Number" faster than she dreamed. You might already have enough too.

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service